MUC16, a large type I transmembrane mucin of the MUC family (Yin and Lloyd, 2001; Thériault et al., 2011; Aithal et al., 2018), is a precursor of the most widely used biomarker for recurrent ovarian cancer, CA125. Here, MUC16 is linked to ovarian carcinoma.